Compare PCRX & MBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PCRX | MBC |
|---|---|---|
| Founded | 2006 | 1954 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Agricultural Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.1B |
| IPO Year | 2010 | 2022 |
| Metric | PCRX | MBC |
|---|---|---|
| Price | $22.51 | $8.16 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 1 |
| Target Price | ★ $37.20 | $15.00 |
| AVG Volume (30 Days) | 579.3K | ★ 2.1M |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 107.44 | N/A |
| EPS | 0.16 | ★ 0.21 |
| Revenue | $541,533,000.00 | ★ $2,734,700,000.00 |
| Revenue This Year | $6.78 | N/A |
| Revenue Next Year | $8.54 | $14.45 |
| P/E Ratio | $139.00 | ★ $39.00 |
| Revenue Growth | ★ 26.04 | 1.27 |
| 52 Week Low | $18.80 | $7.38 |
| 52 Week High | $27.99 | $14.22 |
| Indicator | PCRX | MBC |
|---|---|---|
| Relative Strength Index (RSI) | 49.29 | 37.43 |
| Support Level | $22.57 | $7.38 |
| Resistance Level | $23.94 | $8.78 |
| Average True Range (ATR) | 0.79 | 0.37 |
| MACD | -0.07 | 0.13 |
| Stochastic Oscillator | 49.48 | 55.36 |
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.
MasterBrand Inc operates as a residential cabinet manufacturer in North America. It offers a comprehensive portfolio of residential cabinetry products for the kitchen, bathroom, and other parts of the home. The firm sells its products throughout the United States and Canada through three primary channels: dealers, retailers and builders.